Does APIXABAN Cause Neoplasm malignant? 1,772 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,772 reports of Neoplasm malignant have been filed in association with APIXABAN (ELIQUIS). This represents 1.1% of all adverse event reports for APIXABAN.
1,772
Reports of Neoplasm malignant with APIXABAN
1.1%
of all APIXABAN reports
293
Deaths
153
Hospitalizations
How Dangerous Is Neoplasm malignant From APIXABAN?
Of the 1,772 reports, 293 (16.5%) resulted in death, 153 (8.6%) required hospitalization, and 24 (1.4%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 1,772 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
DENOSUMAB (698)
Which APIXABAN Alternatives Have Lower Neoplasm malignant Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ